Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WA › Ellensburg › NPI 1356375307
Hospital

Kittitas County Public Hospital Dist 1

Kittitas County Public Hospital Dist 1 was paid $39.09M by Medicaid between Jan 2018 and Dec 2024, across 253 billing codes. Its largest line is 74177, Computed tomography, abdomen and pelvis; with contrast material — 14% of everything it billed.

33Billing provider infoKITTITAS COUNTY PUBLIC HOSPITAL DIST 1
ELLENSBURG, WA 98926
33aNPI1356375307assigned 07/10/2006
33bProvider typeCritical Access Hospital
28Total paid$39.09M
24GClaims593,307
24DCodes billed253
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Critical Access Hospital providers in Washington

Rank by total paid#3 of 30
Median peer was paid$9.10M
This provider vs. median4.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201874,357$3.99M
201980,469$4.60M
202075,487$4.76M
202193,531$6.73M
202298,301$7.21M
202398,439$6.64M
2024incomplete72,723$5.15M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
74177 Computed tomography, abdomen and pelvis; with contrast material 14% 3,102 2,793 $5.29M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 11% 23,753 20,515 $4.25M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 11% 13,762 10,223 $4.25M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 4.4% 18,042 16,384 $1.71M
70450 Computed tomography, head or brain; without contrast material 3.5% 2,771 2,478 $1.38M
80053 Comprehensive metabolic panel 2.6% 28,783 23,569 $1.02M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2.4% 9,379 8,632 $927K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.2% 16,538 6,368 $879K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.1% 32,504 25,972 $801K
96361 Intravenous infusion, hydration; each additional hour 1.8% 8,441 5,950 $701K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.7% 5,304 3,414 $659K
G0378 Hospital observation service, per hour 1.7% 1,250 934 $656K
241 more codes
97530 Therapeutic activities, direct patient contact, each 15 minutes 1.7% 10,891 $653K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 1.7% 5,360 $651K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.6% 8,580 $642K
96375 Therapeutic injection; each additional sequential IV push 1.3% 7,357 $527K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 1.3% 5,857 $493K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.2% 442 $462K
84443 Thyroid stimulating hormone (TSH) 1.2% 12,858 $455K
71260 Computed tomography, thorax, diagnostic; with contrast material 1.1% 680 $444K
71045 Radiologic examination, chest; single view 1.1% 6,505 $433K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 1.1% 1,602 $412K
36415 Collection of venous blood by venipuncture 1.1% 44,548 $411K
99213 Doctor's office visit, returning patient (routine) <1% 8,220 $381K
80306 <1% 5,316 $378K
72125 Computed tomography, cervical spine; without contrast material <1% 506 $366K
71046 Radiologic examination, chest; 2 views <1% 2,933 $357K
81001 <1% 16,986 $351K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 4,017 $321K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 7,357 $309K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 7,198 $273K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 15,775 $249K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 4,984 $236K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 4,284 $210K
73030 <1% 1,420 $203K
76830 Ultrasound, transvaginal <1% 1,319 $182K
J7120 Ringers lactate infusion, up to 1000 cc <1% 4,259 $173K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 2,523 $171K
80061 Lipid panel <1% 6,541 $158K
84484 <1% 6,323 $155K
73610 <1% 1,061 $155K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 2,516 $149K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 324 $147K
73630 <1% 1,028 $143K
96376 <1% 2,853 $142K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,917 $138K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,162 $127K
73110 <1% 861 $126K
97162 <1% 1,627 $122K
99214 Doctor's office visit, returning patient (more involved) <1% 1,833 $121K
87086 Culture, bacterial; quantitative colony count, urine <1% 5,266 $113K
87186 <1% 2,663 $109K
73562 <1% 742 $107K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,232 $106K
81025 <1% 4,197 $105K
84439 <1% 3,577 $104K
82728 <1% 2,830 $104K
85027 <1% 4,141 $102K
83036 Hemoglobin; glycosylated (A1C) <1% 5,237 $98K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 98 $96K
73130 <1% 645 $95K
85610 <1% 6,490 $93K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 5,654 $93K
80048 Basic metabolic panel (calcium, ionized) <1% 5,527 $92K
99203 Doctor's office visit, new patient (routine) <1% 1,281 $89K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,013 $89K
84703 <1% 2,675 $88K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 1,226 $88K
87071 <1% 3,322 $88K
86140 <1% 3,705 $88K
85379 <1% 3,390 $87K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,853 $86K
83880 <1% 3,179 $83K
83690 <1% 5,576 $82K
97161 <1% 1,249 $80K
J1170 Injection, hydromorphone, up to 4 mg <1% 3,192 $79K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 7,230 $78K
83605 <1% 6,075 $78K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,945 $77K
85730 <1% 4,529 $73K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,685 $72K
82948 <1% 3,819 $68K
87040 <1% 2,876 $65K
86703 <1% 1,949 $61K
82785 <1% 301 $61K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 240 $61K
72100 <1% 362 $60K
83735 <1% 3,937 $56K
87507 <1% 263 $54K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 2,875 $53K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,904 $49K
71275 Computed tomographic angiography, chest, with contrast material <1% 59 $48K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 3,690 $46K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,909 $46K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 5,096 $43K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 170 $43K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,287 $42K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 258 $41K
J2704 Injection, propofol, 10 mg <1% 2,201 $40K
85652 <1% 2,172 $39K
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 355 $39K
82150 <1% 1,474 $38K
87077 <1% 2,934 $38K
86885 <1% 1,640 $38K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,050 $37K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 146 $31K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 197 $31K
73564 <1% 191 $31K
73502 <1% 216 $30K
83540 <1% 1,790 $29K
84702 <1% 1,232 $28K
86803 <1% 1,416 $26K
74018 <1% 218 $26K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,362 $25K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 758 $25K
97113 <1% 297 $25K
83550 <1% 1,478 $24K
90715 <1% 244 $24K
82607 <1% 820 $23K
J2060 Injection, lorazepam, 2 mg <1% 1,694 $23K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 335 $23K
86900 <1% 1,959 $23K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,451 $22K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,959 $21K
86901 <1% 1,797 $21K
80143 <1% 515 $20K
76801 <1% 132 $20K
86780 <1% 1,480 $20K
82570 <1% 1,308 $20K
80179 <1% 460 $19K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 225 $19K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 27 $19K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 1,804 $19K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 15 $18K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,066 $17K
0240U <1% 2,459 $17K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,377 $17K
87340 <1% 969 $16K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 177 $16K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 85 $16K
81003 <1% 941 $15K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 71 $15K
86701 <1% 529 $14K
76642 <1% 94 $12K
82043 <1% 841 $12K
80076 <1% 464 $12K
86003 <1% 328 $12K
87205 <1% 945 $11K
84100 <1% 721 $10K
59025 Fetal non-stress test <1% 56 $9K
J2270 Injection, morphine sulfate, up to 10 mg <1% 612 $9K
86592 <1% 471 $9K
94060 <1% 57 $8K
82803 <1% 165 $8K
84466 <1% 214 $8K
73140 <1% 68 $7K
72040 <1% 37 $7K
97165 <1% 137 $7K
96367 <1% 182 $7K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 13 $6K
84145 <1% 138 $6K
86762 <1% 330 $6K
93971 <1% 78 $5K
82947 <1% 229 $5K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 276 $5K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 61 $5K
99215 Doctor's office visit, returning patient (complex) <1% 50 $5K
82950 <1% 126 $4K
J2550 Injection, promethazine hcl, up to 50 mg <1% 556 $4K
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 61 $4K
J7030 Infusion, normal saline solution , 1000 cc <1% 107 $4K
87210 <1% 217 $4K
81015 <1% 407 $4K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 171 $4K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 252 $4K
87420 <1% 89 $4K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 28 $3K
86038 <1% 143 $3K
J3490 Unclassified drugs <1% 1,459 $3K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 145 $3K
84403 <1% 124 $3K
73080 <1% 26 $3K
86787 <1% 193 $3K
99152 <1% 350 $3K
76770 <1% 12 $3K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 39 $3K
87081 <1% 80 $3K
S0164 Injection, pantoprazole sodium, 40 mg <1% 380 $3K
76857 <1% 15 $3K
82784 <1% 57 $3K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 86 $2K
80047 <1% 103 $2K
74019 <1% 13 $2K
83655 <1% 132 $2K
73590 <1% 13 $2K
J1650 Injection, enoxaparin sodium, 10 mg <1% 109 $2K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 270 $2K
87088 <1% 106 $2K
94729 <1% 25 $2K
12001 <1% 16 $1K
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 90 $1K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,138 $1K
87486 <1% 85 $1K
82550 <1% 76 $1K
87581 <1% 85 $1K
99153 Mod sedat endo service >5yrs <1% 143 $1K
73010 <1% 12 $1K
86704 <1% 24 $1K
A9270 Non-covered item or service <1% 6,937 $1K
73560 <1% 16 $1K
84550 <1% 56 $936.44
86999 <1% 87 $809.54
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg <1% 137 $800.22
0352U <1% 341 $766.16
85014 <1% 114 $761.15
85007 <1% 229 $747.44
97803 <1% 16 $706.41
86308 <1% 28 $688.38
86695 <1% 43 $650.02
J1644 Injection, heparin sodium, per 1000 units <1% 83 $604.88
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 12 $571.67
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 16 $552.67
36000 <1% 12 $543.52
80178 <1% 32 $526.64
J7050 Infusion, normal saline solution, 250 cc <1% 28 $514.09
84146 <1% 28 $509.95
83516 <1% 17 $499.45
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 51 $467.78
94726 <1% 13 $465.16
86696 <1% 30 $453.89
J3475 Injection, magnesium sulfate, per 500 mg <1% 19 $414.43
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 94 $395.59
C9113 Injection, pantoprazole sodium, per vial <1% 26 $386.72
97535 Self-care/home management training, each 15 minutes <1% 16 $367.24
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 386 $359.26
82746 <1% 14 $324.38
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 28 $311.21
J1630 Injection, haloperidol, up to 5 mg <1% 28 $299.53
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 181 $297.27
84480 <1% 15 $261.94
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 20 $261.20
82274 <1% 15 $217.63
97116 <1% 17 $204.48
86480 <1% 12 $178.49
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 24 $170.12
87150 <1% 136 $152.29
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 17 $111.99
85008 <1% 231 $104.33
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) <1% 17 $98.61
80320 <1% 1,162 $77.08
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 2,391 $8.35
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 36 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 69 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLITTKE, BECKY (REVENUE CYCLE DIRECTOR)
Same official

Other billing entities under LITTKE, BECKY

Full network →
ProviderLocationPaid
Kittitas County Public Hospital Dist 1Ellensburg, WA$19.47M
Kittitas County Public Hospital Dist 1Ellensburg, WA$377K
Kittitas County Public Hospital Dist 1Ellensburg, WA$1K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.